FDA Registered and Inspected 503B Outsourcing Facility
PANACEUTICS NAMES TOP SPECIALTY PHARMACY EXECUTIVE MARK MONTGOMERY CHIEF EXECUTIVE OFFICER Co‐Founder L. Staton Noel III joins full‐time as CSO and Scientific Advisory Board Expands Panaceutics, Inc., a personalized medicine and clinical nutrition company, today announced it has named specialty pharmacy executive Mark Montgomery to the position of Chief Executive Officer, effectively immediately. He was recruited by Edison Hudson, co‐ founder who will remain at the company as Chief Technology Officer. The combination of Montgomery’s leadership in the specialty pharmacy field, Hudson’s robotics expertise, and Noel’s experience in drug product development positions the Company to commercialize its proprietary “pill‐ free” methods of delivering personalized medicine and wellness. Montgomery was president and CEO of Axium Healthcare, Inc., which merged with Kroger Company in 2012, where he has served as strategic advisor. As the fifth largest pharmacy in the United States, Kroger acquired Mark’s company and saw him lead it to becoming one of their fastest growing business units. Mark was Vice President of CareMark, acquired by CVS, and was head of Sunrise Health Management, which was acquired by Accredo Health, the nation’s largest specialty pharmacy. Hudson states, “We actively recruited Mark to lead Panaceutics as we enter our fifth year, recognizing our need for his deep industry knowledge and connections to take our disruptive healthcare technology platform to commercial use. We are extremely fortunate to have such a proven and respected executive join our team. In addition, the company also announced that its co‐founder L. Staton Noel III, has joined the company full‐time in his role as Chief Scientific Officer. Noel was previous Director for the Office of Innovation Commercialization at UNCG and has a master’s degree in Gerontology and a MBA. Prior to that, Noel spent 20 years at GlaxoSmithKline in drug discovery for metabolic diseases, inflammation, women’s and men’s health, and aging. Noel and Hudson founded the company and are the named inventors of the issued patents.The Company has also substantially enhanced its Advisory Board to include several accomplished experts and executives with experience ranging from pharmaceutics to cardiology to personalization methods.